Early initiation of sodium‐glucose linked transporter inhibitors (SGLT‐2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients

There is a paucity of data on the use of SGLT2 inhibitors on outcomes in kidney transplant recipients. There may be concern in initiating these agents, especially within the first year post‐transplant when renal function is more labile and immunosuppression more intense, due to a presumed high risk...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Endocrinol Diabetes Metab
Autori principali: Song, Chelsey Chenxi, Brown, Andrew, Winstead, Ryan, Yakubu, Idris, Demehin, Moses, Kumar, Dhiren, Gupta, Gaurav
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029504/
https://ncbi.nlm.nih.gov/pubmed/33855198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.185
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi